Michael Ujiki to Weight Loss
This is a "connection" page, showing publications Michael Ujiki has written about Weight Loss.
Connection Strength
1.603
-
Efficacy of a Required Preoperative Weight Loss Program for Patients Undergoing Bariatric Surgery. J Gastrointest Surg. 2016 Apr; 20(4):667-73.
Score: 0.411
-
Impact of preoperative depression severity and antidepressant medication use on perioperative outcomes and long-term weight loss following primary bariatric surgery. Surg Endosc. 2026 Aug; 40(8):7133-7142.
Score: 0.211
-
Loop duodenal switch confers more complications with little gain of weight loss compared to Roux-en-Y gastric bypass. Surg Endosc. 2025 02; 39(2):1261-1268.
Score: 0.189
-
Comparable improvement and resolution of obesity-related comorbidities in endoscopic sleeve gastroplasty vs laparoscopic sleeve gastrectomy: single-center study. Surg Endosc. 2024 10; 38(10):5914-5921.
Score: 0.186
-
Patient-reported bowel and bladder function is not adversely impacted by bariatric surgery. Surg Endosc. 2022 09; 36(9):6896-6902.
Score: 0.155
-
Endoscopic gastrojejunostomy revision is more effective than medical management alone to address weight regain after RYGB. Surg Endosc. 2018 03; 32(3):1564-1571.
Score: 0.118
-
Outcomes following 50 consecutive endoscopic gastrojejunal revisions for weight gain following Roux-en-Y gastric bypass: a comparison of endoscopic suturing techniques for stoma reduction. Surg Endosc. 2017 06; 31(6):2667-2677.
Score: 0.108
-
Management options for obesity after bariatric surgery. Surg Laparosc Endosc Percutan Tech. 2015 Feb; 25(1):15-18.
Score: 0.096
-
Randomized Controlled Trial Based US Commercial Payor Cost-Effectiveness Analysis of Endoscopic Sleeve Gastroplasty Versus Lifestyle Modification Alone for Adults With Class I/II Obesity. Obes Surg. 2024 09; 34(9):3275-3284.
Score: 0.046
-
Endoscopic sleeve gastroplasty as an early tool against obesity: a multicenter international study on an overweight population. Gastrointest Endosc. 2024 03; 99(3):371-376.
Score: 0.044
-
Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022 08 06; 400(10350):441-451.
Score: 0.040